DE69416824D1 - Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen - Google Patents

Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen

Info

Publication number
DE69416824D1
DE69416824D1 DE69416824T DE69416824T DE69416824D1 DE 69416824 D1 DE69416824 D1 DE 69416824D1 DE 69416824 T DE69416824 T DE 69416824T DE 69416824 T DE69416824 T DE 69416824T DE 69416824 D1 DE69416824 D1 DE 69416824D1
Authority
DE
Germany
Prior art keywords
pct
hiv
polypeptides
polypeptide
products made
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69416824T
Other languages
English (en)
Other versions
DE69416824T2 (de
Inventor
Akiyoshi Matsumoto
Michinori Waki
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Publication of DE69416824D1 publication Critical patent/DE69416824D1/de
Application granted granted Critical
Publication of DE69416824T2 publication Critical patent/DE69416824T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69416824T 1993-10-14 1994-10-12 Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen Expired - Fee Related DE69416824T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28034693 1993-10-14
PCT/JP1994/001706 WO1995010534A1 (en) 1993-10-14 1994-10-12 Polypeptide and anti-hiv agent prepared therefrom

Publications (2)

Publication Number Publication Date
DE69416824D1 true DE69416824D1 (de) 1999-04-08
DE69416824T2 DE69416824T2 (de) 1999-07-08

Family

ID=17623732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69416824T Expired - Fee Related DE69416824T2 (de) 1993-10-14 1994-10-12 Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen

Country Status (17)

Country Link
US (1) US5776899A (de)
EP (1) EP0677061B1 (de)
JP (1) JPH08504837A (de)
KR (1) KR100208873B1 (de)
CN (1) CN1038841C (de)
AT (1) ATE177114T1 (de)
AU (1) AU682405B2 (de)
CA (1) CA2151283A1 (de)
CZ (1) CZ287239B6 (de)
DE (1) DE69416824T2 (de)
FI (1) FI952900A (de)
HU (1) HU217442B (de)
NO (1) NO952321L (de)
NZ (1) NZ274560A (de)
RU (1) RU2136696C1 (de)
WO (1) WO1995010534A1 (de)
ZA (1) ZA948005B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
US5693486A (en) * 1993-07-20 1997-12-02 Intrabiotics DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins
US6653442B1 (en) 1993-07-20 2003-11-25 Intrabiotics Pharmaceuticals, Inc. Protegrins
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity
US6329498B1 (en) 1996-10-15 2001-12-11 Seikagaku Corporation Polypeptide transition metal salts and method of enhancing anti-HIV activity of polypeptide
AU6518698A (en) * 1997-03-28 1998-10-22 Seikagaku Corporation Novel anti-hiv complexes and medicinal compositions
PL354122A1 (en) * 1999-08-09 2003-12-29 Tripep Abtripep Ab Pharmaceutical compositions containing tripeptides
US6337317B1 (en) 2000-06-27 2002-01-08 The University Of British Columbia Antimicrobial peptides and methods of use thereof
CA2421183C (en) 2000-09-05 2015-06-16 Seikagaku Corporation Novel polypeptide and anti-hiv agent containing the same
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
EP1436317A1 (de) * 2001-09-19 2004-07-14 Tripep Ab Moleküle, die die virale infektivität hemmen, und verfahren zu deren anwendung
KR100932520B1 (ko) * 2002-10-31 2009-12-17 박래옥 항암제 조성물
EP1541585B1 (de) * 2002-08-27 2013-01-30 Biokine Therapeutics Ltd. Cxcr4-antagonist und dessen verwendung
JP4781621B2 (ja) * 2002-08-27 2011-09-28 バイオカイン セラピューティックス リミテッド Ｃｘｃｒ４拮抗薬およびその用途
EP1565195B1 (de) * 2002-10-31 2008-07-23 Lae-Ok Park Antikrebs- und antivirale zusammensetzung
US20040132642A1 (en) * 2002-11-12 2004-07-08 Government Of The U.S.A., Represented By The Secretary, Dept. Of Health & Human Services Methods of inhibiting metastasis or growth of a tumor cell
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
AU2004212786A1 (en) * 2003-02-21 2004-09-02 Tripep Ab Glycinamide derivative for inhibiting HIV replication
AU2003232253A1 (en) 2003-05-02 2004-11-23 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
CA2645342A1 (en) 2006-03-10 2007-09-20 Peptcell Limited Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof
CN100366633C (zh) * 2006-04-18 2008-02-06 河北师范大学 棕点湍蛙抗病毒多肽及其在制药中的应用
EP3011961B1 (de) 2006-12-21 2020-11-11 Biokine Therapeutics LTD. 4f-benzoyl-tn14003 für die mobilisierung von hämotopoietischen vorläuferzellen im hinblick auf transplantation
US9271933B2 (en) * 2007-11-27 2016-03-01 Rutgers, The State University Of New Jersey Graft copolymer polyelectrolyte complexes for drug delivery
US9789194B2 (en) 2007-11-27 2017-10-17 Rutgers, The State University Of New Jersey Graft copolymer polyelectrolyte complexes for drug delivery
EP2328928A2 (de) 2008-08-25 2011-06-08 Dana-Farber Cancer Institute, Inc. Konserviertes influenzahämagglutininepitop und antikörper dagegen
JP5715622B2 (ja) 2009-06-14 2015-05-07 バイオカイン セラピューティックス リミテッド 血小板レベルを増大させるためのペプチド療法
CN103703018B (zh) 2011-06-07 2016-10-26 波利弗尔股份公司 作为CXC4拮抗剂的β-发夹肽模拟物
EP2841084B1 (de) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs
CN104072579B (zh) * 2014-06-11 2017-01-25 南方医科大学 具有抗菌抗病毒活性的小分子肽及其活性修饰物
JP2018521983A (ja) 2015-07-16 2018-08-09 バイオカイン セラピューティックス リミテッド がんを治療するための組成物および方法
BR112018016924A2 (pt) 2016-02-23 2019-01-02 Biokine Therapeutics Ltd método de seleção de regime de tratamento para indivíduo que tem leucemia mieloide aguda (lma), método de maximização de resposta ao tratamento de leucemia mieloide aguda (lma), método de tratamento de lma, antagonista de cxcr4 e agente quimioterápico no tratamento de lma
RU2658781C1 (ru) * 2017-12-28 2018-06-22 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Пептид, обладающий противоопухолевой активностью
CN110841607B (zh) * 2019-11-22 2020-07-24 中国科学院地质与地球物理研究所 一种超低本底金特效树脂及其制备和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
JP2641742B2 (ja) * 1988-08-18 1997-08-20 マルハ株式会社 新規ペプチド及び抗菌剤
JP2641744B2 (ja) * 1988-08-18 1997-08-20 マルハ株式会社 新規ペプチド及び抗菌剤
JP2798711B2 (ja) * 1988-09-26 1998-09-17 生化学工業株式会社 ポリペプチド系抗ウィルス剤
ES2081491T3 (es) * 1990-09-11 1996-03-16 Seikagaku Kogyo Co Ltd Nuevo polipeptido y farmaco anti-vih preparado a partir de este polipeptido.
HUT61036A (en) * 1991-05-02 1992-11-30 Seikagaku Kogyo Co Ltd Process for producing new polypeptides capable of linking to lipopolysaccharides and pharmaceutical compositions comprising same as active ingredients
JP3266311B2 (ja) * 1991-05-02 2002-03-18 生化学工業株式会社 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
JP2500194B2 (ja) 1993-08-10 1996-05-29 株式会社ヴァンドームヤマダ 商品発注システム

Also Published As

Publication number Publication date
KR100208873B1 (ko) 1999-07-15
CZ153395A3 (en) 1995-12-13
FI952900A0 (fi) 1995-06-13
RU95112539A (ru) 1997-06-27
HU217442B (hu) 2000-01-28
ATE177114T1 (de) 1999-03-15
CN1038841C (zh) 1998-06-24
ZA948005B (en) 1996-02-06
HUT72974A (en) 1996-06-28
US5776899A (en) 1998-07-07
AU7862894A (en) 1995-05-04
HU9501719D0 (en) 1995-08-28
AU682405B2 (en) 1997-10-02
DE69416824T2 (de) 1999-07-08
NO952321D0 (no) 1995-06-13
EP0677061A1 (de) 1995-10-18
JPH08504837A (ja) 1996-05-28
CZ287239B6 (en) 2000-10-11
EP0677061B1 (de) 1999-03-03
CN1116427A (zh) 1996-02-07
CA2151283A1 (en) 1995-04-20
NO952321L (no) 1995-08-09
RU2136696C1 (ru) 1999-09-10
NZ274560A (en) 1998-03-25
FI952900A (fi) 1995-06-13
WO1995010534A1 (en) 1995-04-20

Similar Documents

Publication Publication Date Title
DE69416824D1 (de) Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
AU645709B2 (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
BR9611175B1 (pt) compostos e composiÇÕes farmacÊuticas.
NO306346B1 (no) N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat
DE69316217T2 (de) Anwendung von nor- und homo-gallensäurederivaten als absorptienförderer für arzneimittel
ES2178657T3 (es) Derivados lipopeptidos, procedimiento para su preparacion y su empleo.
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
ATE175669T1 (de) Sulfonylaminopyrimidine, ihre herstellung und verwendung als heilmittel
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2095726T3 (es) Piperazinas sustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
SE9402241D0 (sv) Inhibitor
ZA885335B (en) Leukotriene antagonists,processes for the preparation thereof,the use thereof for the treatment of diseases,and precursors
ATE144986T1 (de) Aminoacylderivate von gem- diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
JO1711B1 (en) Therapeutic agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: YAMAMOTO, NAOKI, TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee